Cargando…
Lack of Parkinsonian Pathology and Neurodegeneration in Mice After Long-Term Injections of a Proteasome Inhibitor in Olfactory Bulb and Amygdala
Proteinaceous inclusions, called Lewy bodies (LBs), are used as a pathological hallmark for Parkinson’s disease (PD). Recent studies suggested a prion-like spreading mechanism for α-synucleinopathy where early neuropathological deposits occur, among others, in the olfactory bulb (OB) and amygdala. L...
Autores principales: | del Rey, Natalia Lopez-Gonzalez, Balzano, Tiziano, Martin-Rodriguez, Lucia, Salinas-Rebolledo, Constanza, Trigo-Damas, Ines, Rojas-Fernandez, Alejandro, Alvarez-Erviti, Lydia, Blesa, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570189/ https://www.ncbi.nlm.nih.gov/pubmed/34744683 http://dx.doi.org/10.3389/fnagi.2021.698979 |
Ejemplares similares
-
Olfactory bulb surroundings can help to distinguish Parkinson’s disease from non-parkinsonian olfactory dysfunction
por: Tremblay, Cécilia, et al.
Publicado: (2020) -
Is abnormal metabolism in the olfactory bulb and amygdala associated with bipolar disorder?
por: Sancaktar, Muhammet, et al.
Publicado: (2023) -
Neurodegeneration in the olfactory bulb and olfactory deficits in the Ccdc66 -/- mouse model for retinal degeneration
por: Schreiber, Sabrina, et al.
Publicado: (2018) -
Prohibitins in neurodegeneration and mitochondrial homeostasis
por: Fernandez-Abascal, Jesus, et al.
Publicado: (2022) -
Astrogliosis and sexually dimorphic neurodegeneration and microgliosis in the olfactory bulb in Parkinson’s disease
por: Flores-Cuadrado, Alicia, et al.
Publicado: (2021)